Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1981-08-12
1983-02-22
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
260112R, 2601125R, 260117, 260118, 424 9, 424 95, 424101, 435 4, 435212, 435214, 435268, 435273, A61K 3702, A61K 3712, C12P 2106, C12N 900, C07G 700
Patent
active
043748309
ABSTRACT:
Novel hemostatic agent comprises equine arterial fibrillar collagen in a carrier. The agent is useful for the aggregation of platelets for clinical diagnostic tests and for the clotting of blood, such as for controlling bleeding in warm blooded species. The fibrillar collagen is obtained by extracting homogenized equine arterial tissue with aqueous solutions followed by extensive dialysis.
REFERENCES:
patent: 4347243 (1982-08-01), Schneider
Fagelson Anna P.
Research Corp.
LandOfFree
Platelet aggregating material from equine arterial tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregating material from equine arterial tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregating material from equine arterial tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1373196